NOVO NORDISK A/S Bagsværd, Denmark, 7 February 2017 - Novo Nordisk has published its 2016 annual report online at http://www.novonordisk.com/annualreport. It is the company's thirteenth integrated annual report detailing the company's financial, social and environmental performance.
The annual report will be available in print later this month.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube
Further informationMedia: | ||
Katrine Sperling | +45 4442 6718 | krsp@novonordisk.com |
Ken Inchausti (US) | +1 609 514 8316 | kiau@novonordisk.com |
Investors: | ||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com |
Hanna Ögren | +45 3079 8519 | haoe@novonordisk.com |
Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com |
Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Novo Allé
2880 Bagsværd Denmark
Telephone:
+45 4444 8888
Internet: www.novonordisk.com CVR no:
24 25 67 90
Novo Nordisk A/S published this content on 07 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 07 February 2017 08:14:02 UTC.
Original documenthttp://www.novonordisk.com/bin/getPDF.2076282.pdf
Public permalinkhttp://www.publicnow.com/view/DDEE22FB6C08C36DBBF4663F81BE0249ECE48AC7
